
Salvage Isatuximab Combo Elicits Efficacy in Lenalidomide-Relapsed Myeloma
Combining isatuximab-irfc (Sarclisa) with carfilzomib (Kyprolis) and dexamethasone (IsaKd) demonstrated efficacy and safety as a first-salvage therapeutic option among patients with multiple myeloma who have relapsed on lenalidomide (Revlimid), according …